The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
  • Is CBD ‘Harmful’ to Our Liver? No.
  • Industry Leaders Leading Turnaround in Marijuana Stocks?
Psychedelic Stocks
Exploring the companies and themes that make up this emerging and exciting new sector

IntelGenx Enters into Feasibility Agreement with ATAI Life Sciences to Develop Pharmaceutical-Grade Polymeric Film-Based Psychedelics

2020-08-20 PSW Editor

IntelGenX enters into agreement with ATAI Life Sciences to develop novel formulations of pharmaceutical-grade psychedelics.

ATAI Life Sciences Forges Premier Psychedelics R&D Platform

2020-08-20 PSW Editor

ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.

PSYC Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights

2020-08-19 PSW Editor

Global Trac Solutions is developing a media partnership with Microdose.

Psychedelics and Cannabis: Part 2, Industry Overlap

2020-08-14 Jeff Nielson

Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.

New Psychedelic Research Nonprofit Teams with Johns Hopkins University for Real-World Study on Use of Psilocybin Mushrooms

2020-08-14 PSW Editor

Unlimited Science, a psychedelics non-profit R&D organization, is collaborating with Johns Hopkins.

Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results

2020-08-14 PSW Editor

MindMed reported a net loss of $5.8 million for first 6 months of 2020, has USD $24 million in cash.

MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

2020-08-13 PSW Editor

MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.

Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug

2020-08-13 PSW Editor

Tryp Therapeutics adds a partner to advance its drug manufacturing capabilities.

MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

2020-08-13 PSW Editor

MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.

Psychedelics and Cannabis: Part 1, Regulatory Déjà Vu

2020-08-12 Jeff Nielson

There are obvious parallels between cannabis and psychedelics decriminalization. Are there are also differences?

Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector

2020-08-12 PSW Editor

Mydecine's corporate update notes its "world's first" clinical trials initiative for PTSD.

GHP Noetic Science-Psychedelic Pharma Inc. Announces Closing of Initial Public Offering

2020-08-12 PSW Editor

A new psychedelics company began trading August 11th.

  • Previous
  • 1
  • ...
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • ...
  • 74
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

2020-08-31
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

What Does Field Trip Psychedelics Offer Investors?

Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll

Psychedelic Stocks
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2023, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor